Stratasys(SSYS)

Search documents
SSYS Q2 Revenues Miss: Will FY24 Outlook Drag Shares Down?
ZACKS· 2024-08-30 17:11
Financial Performance - Stratasys reported a loss of 4 cents per share in Q2 2024, in line with the Zacks Consensus Estimate, compared to non-GAAP earnings of 4 cents per share in the year-ago quarter [1] - Quarterly revenues declined 13.6% YoY to $138 million, missing the consensus mark by 6.78%, partially due to divestitures and unfavorable foreign currency exchange rates [1] - Non-GAAP gross profit fell 9.8% YoY to $67.7 million, while the non-GAAP gross margin expanded 50 bps to 49% [2] - Non-GAAP operating expenses decreased 2.2% YoY to $70.9 million, resulting in a non-GAAP operating loss of $3.2 million, compared to a profit of $5 million in the year-ago quarter [2] - Adjusted EBITDA plunged 78.3% YoY to $2.3 million [2] Segment Performance - Product revenues declined 14.2% YoY to $93.6 million, with System revenues plunging 40% YoY to $29 million, while Consumables revenues increased 6.3% YoY to $64.6 million [2] - Services revenues declined 12.2% YoY to $44.4 million, with Customer Support revenues advancing 3.8% YoY to $30.5 million [2] Strategic Developments - Stratasys solidified a partnership with AM Craft to support additive manufacturing of EASA-certified aircraft sustainment parts, opening new opportunities in the aviation sector [3] - The company launched new products, including SAF High-Def printing capabilities, H350 version 1.5, and SAF Polypropylene material, expanding manufacturing applications and use cases [3] - Stratasys software offerings, including GrabCAD Print Pro and GrabCAD Streamline Pro, showed strong demand, with Print Pro expanding to PolyJet users and Streamline Pro gaining traction [3] Balance Sheet & Cash Flow - Stratasys ended Q2 with cash and short-term deposits of $150.9 million, down from $161.1 million at the end of the previous quarter [4] - The company reported a negative operating cash flow of $2.4 million, a significant decline from the positive operating cash flow of $7.3 million in the previous quarter [4] 2024 Outlook - Management lowered 2024 revenue projections to $570-$580 million, down from the previous forecast of $630-$645 million [5][6] - Non-GAAP earnings per share are now forecasted at 1-5 cents, compared to the previous range of 12-19 cents [5][6] - Gross margins are expected to be between 48.7% and 49%, down from the previous range of 49%-49.5% [5][6] - Non-GAAP operating margin is projected at 0.5%-1%, compared to the previous range of 2.5%-3.5% [5][6] - Operating expenses are estimated at $276-$278 million, down from the previous range of $292-$297 million [5][6] - Adjusted EBITDA is projected at $24-$27 million, down from the previous range of $40-$45 million [5][6] Stock Performance - Stratasys' shares have plunged 51.5% year-to-date, underperforming the Zacks Computer & Technology sector's rise of 20.3% [6]
Stratasys Analysts Cut Their Forecasts After Q2 Results
Benzinga· 2024-08-30 13:28
Stratasys Ltd. SSYS reported worse-than-expected second-quarter sales and cut its FY24 guidance on Thursday.Stratasys reported fiscal second-quarter 2024 revenue of $138.04million, missing the analyst consensus estimate of $146.34 million. Adjusted EPS loss of 4 cents beat the analyst consensus estimate of 5 cent loss.The company shared plans to downsize its workforce by 15% by 2024 end to save $40 million in annual cost beginning in the first quarter of 2025, along with annualized EBITDA margins of 8%.Stra ...
Why Stratasys Stock Sank 15% Today
The Motley Fool· 2024-08-29 17:24
Stratasys stock is 3D printing nothing but losses these days.Stratasys (SSYS -14.71%) stock fell 14.9% through 12:05 p.m. on mixed earnings on Thursday.Wall Street analysts had forecast the 3D printing company would lose $0.05 per share in the second quarter, and the good news is that Stratasys beat that estimate -- losing "only" $0.04. The bad news is that Stratasys fell well short of Street forecasts for $146.3 million in Q2 sales, reporting only $138 million. Stratasys' Q2 earningsThis news gets worse. T ...
Stratasys(SSYS) - 2024 Q2 - Earnings Call Transcript
2024-08-29 15:42
Stratasys Ltd. (NASDAQ:SSYS) Q2 2024 Earnings Conference Call August 29, 2024 8:30 AM ET Company Participants Yonah Lloyd - Chief Communications Officer and VP, IR Yoav Zeif - CEO Eitan Zamir - CFO Conference Call Participants Greg Palm - Craig Hallum James Ricchiuti - Needham & Company Troy Jensen - Cantor Fitzgerald Jacob Stephan - Lake Street Capital Markets Brian Drab - William Blair Ananda Baruah - Loop Capital Markets Operator Hello, and welcome to the Stratasys’ Q2 2024 Earnings Call and Webcast. At ...
Stratasys (SSYS) Reports Q2 Loss, Lags Revenue Estimates
ZACKS· 2024-08-29 13:11
Stratasys (SSYS) came out with a quarterly loss of $0.04 per share in line with the Zacks Consensus Estimate. This compares to earnings of $0.04 per share a year ago. These figures are adjusted for non-recurring items.A quarter ago, it was expected that this maker of 3D printers would post a loss of $0.04 per share when it actually produced a loss of $0.02, delivering a surprise of 50%.Over the last four quarters, the company has surpassed consensus EPS estimates just once.Stratasys, which belongs to the Za ...
Stratasys Gears Up to Report Q2 Earnings: Key Factors to Note
ZACKS· 2024-08-27 17:11
Stratasys (SSYS) is slated to release second-quarter 2024 results on Aug. 29.The Zacks Consensus Estimate for Stratasys’ second-quarter revenues is pegged at $148.08 million, indicating a year-over-year decrease of 7.31%. The consensus mark for the bottom line is pegged at a loss of 4 cents per share. SSYS posted non-GAAP earnings of 4 cents per share in the year-ago quarter.Its earnings beat the Zacks Consensus Estimate twice in the trailing four quarters, matched once and missed once, the average surprise ...
CollPlant and Stratasys Announce Pre-clinical Study for Regenerative Commercial-Sized Breast Implants
Prnewswire· 2024-08-19 12:30
3D Printed Breast implants consisting of 200cc in volume of CollPlant's rhCollagen-based bioinks produced on a Stratasys' Origin® printer to be testedTechnology innovation addresses a $3.0 billion market opportunity Study to focus on ability of implants to grow natural breast tissue and completely degrade over time REHOVOT, Israel & EDEN PRAIRIE, Minn., Aug. 19, 2024 /PRNewswire/ -- In a significant step in the advancement of regenerative medicine, CollPlant Biotechnologies (Nasdaq: CLGN) and Stratasys Ltd. ...
Stratasys (SSYS) Launches New Dental 3D Printer DentaJet XL
ZACKS· 2024-07-12 15:25
Stratasys (SSYS) announced the launch of the latest innovation in dental 3D printing technology, DentaJet XL. This latest 3D printer aims to reduce costs and improve dental lab productivity with its Super High-Speed mode, large print tray, minimal post-processing workflow and larger resin cartridges. The new printer is designed to work with minimal human intervention. It could reduce labor costs up to 90% with its advanced software prep, unattended printed and curing and print management features. The prin ...
Stratasys (SSYS) Tests 3D Printed Models in Orthopedic Oncology
ZACKS· 2024-06-27 14:16
Stratasys (SSYS) and Ricoh USA, Inc. have announced the commencement of a clinical study to evaluate the efficacy of 3D printed anatomical models in preoperative planning and tumor excision. This innovative approach aims to challenge the current standard of care, which relies solely on CT or MRI imaging.The study, which enrolled its first patient recently, will compare surgical outcomes between two groups, one using 3D printed models alongside traditional imaging for planning and another using imaging alone ...
First patient enrolled in landmark clinical study to assess 3D printed models for orthopedic tumor removal
Prnewswire· 2024-06-26 12:15
Stratasys and Ricoh co-sponsor clinical study comparing the efficacy of 3D printed models to traditional CT or MRI scanning for bone tumor excision planningEXTON, Pa. and EDEN PRAIRIE, Minn. and REHOVOT, Israel, June 26, 2024 /PRNewswire/ -- Ricoh USA, Inc. and Stratasys Ltd. (NASDAQ: SSYS) today announced the enrollment of the first patient in a groundbreaking clinical study aimed to evaluate the use of 3D printed models for orthopedic oncology. The study will assess the efficacy of patient-specific 3D pri ...